CB2R agonist 1, a selective ligand for the cannabinoid receptor subtype 2 (CB2R), demonstrates a high affinity and excellent selectivity, with an EC50 value of 0.56 µM, favoring human CB2R over CB1R. It plays an immunomodulatory role by regulating the production of both pro-inflammatory and anti-inflammatory cytokines.